FDA DISCUSSION, page-14

Interesting article

3 February 2018, 05:39 GMT+11

https://www.bloomberg.com/view/articles/2018-02-02/-right-to-try-law-won-t-lead-to-miracle-cures

...............One critic of the bill, NYU bioethics professor Alison Bateman-House, has been working on a panel devoted to helping terminally ill patients get access to experimental drugs. She’s therefore on board with the ostensible goal of right-to-try. But in her research, she’s found that the barrier -- when there is one -- isn’t FDA red tape but refusal on the part of drug companies or doctors. Under the current system, she said, the FDA approves 99 percent of requests within one day for emergencies and four days for non-emergencies.

"Refusal on the part of drug companies" .... gee there's a surprise NOT

... scared that some of these therapies may just work and create problems for their products making them billions ??